The Differential Diagnosis of Chronic Cough

A persistent cough, defined as one lasting for eight weeks or longer, is a common and often frustrating medical problem. Finding relief depends on a systematic investigation to determine the underlying cause. This process, known as a differential diagnosis, involves exploring a range of possibilities, from frequent conditions to less common external factors. The goal is to isolate the specific trigger responsible for the persistent irritation of the cough reflex pathway.

The Primary Causes of Persistent Cough

The majority of chronic cough cases (up to 95% in non-smokers with a normal chest X-ray) are attributed to a trio of conditions. The first is Upper Airway Cough Syndrome (UACS), previously called post-nasal drip. This occurs when secretions from the nose and sinuses drain down the back of the throat, irritating sensory nerve endings and triggering a cough reflex.

Gastroesophageal Reflux Disease (GERD) is the second major contributor to chronic cough. GERD-related coughing happens through two distinct mechanisms: direct and indirect. Direct irritation occurs when stomach acid flows back to the larynx and pharynx, stimulating cough receptors. The indirect mechanism involves acid reflux stimulating vagus nerve endings in the lower esophagus, triggering a reflex cough even if the acid does not enter the upper airway. This cough can occur even in cases of “silent reflux” (LPR), where typical GERD symptoms like heartburn are absent.

The third primary cause involves inflammation of the lower airways: Asthma and Non-Asthmatic Eosinophilic Bronchitis (NAEB). In both conditions, the airways become hypersensitive, often reacting to non-specific triggers like cold air or exercise. Asthma-related cough is sometimes the sole symptom, particularly in cough-variant asthma. NAEB is characterized by an accumulation of eosinophils, a type of white blood cell, in the lining of the bronchi, causing inflammation and subsequent coughing without the airflow limitation seen in classic asthma.

External and Less Frequent Contributors

Beyond the common causes, a thorough differential diagnosis must account for external factors and less frequent medical conditions. A common external cause is the use of Angiotensin-Converting Enzyme (ACE) inhibitors, medications used to treat high blood pressure and heart failure. Approximately 5% to 35% of patients taking these drugs develop a persistent, dry cough. This occurs because the medication prevents the breakdown of inflammatory mediators like bradykinin and substance P. This accumulation sensitizes the cough reflex, and the cough typically resolves within one to four weeks after stopping the medication.

Other contributors include post-infectious etiologies, where a cough lingers long after a respiratory infection has cleared. This happens following common colds or, more notably, after infections like pertussis (whooping cough). Environmental or occupational exposures, such as inhaling dust, chemical fumes, or irritants, can also provoke chronic airway irritation.

While rare, certain “red flag” symptoms suggest a more serious underlying disease. These symptoms include coughing up blood (hemoptysis), unexplained weight loss, recurrent fever, or recurrent pneumonia. The presence of such findings necessitates immediate investigation to rule out conditions like lung cancer, chronic infections, or heart failure, which require urgent intervention.

Navigating the Diagnostic Steps

The process of diagnosing chronic cough begins with a detailed patient history and physical examination, providing initial clues for targeted testing. The provider inquires about the cough’s duration, specific triggers, and associated symptoms, such as heartburn or nasal congestion. A full review of all medications is mandatory to identify potential drug side effects, especially ACE inhibitors.

Initial testing typically includes a chest X-ray to rule out structural lung disease, such as pneumonia or lung masses. Pulmonary Function Testing, particularly spirometry, is often performed next to measure airflow and assess for conditions like asthma or chronic obstructive pulmonary disease (COPD). If spirometry is normal but asthma is suspected, a methacholine challenge test may be used to check for airway hyper-responsiveness.

If the initial evaluation does not reveal a definitive cause, the provider often moves to sequential therapeutic trials. This involves treating the most likely common causes—UACS, GERD, and asthma—empirically for a set period (usually several weeks) to see if the cough resolves. For instance, a trial of nasal steroids and antihistamines may be given for suspected UACS, or acid-suppressing medication for presumed GERD. A positive response to a specific treatment often confirms the underlying diagnosis, allowing the provider to avoid more expensive or invasive procedures.

Understanding Unexplained Chronic Cough

A significant number of patients still have a persistent cough even after a thorough workup and failed therapeutic trials. This condition is known as Unexplained Chronic Cough (UCC) or Refractory Chronic Cough. UCC is primarily a disorder of nerve function, termed Cough Hypersensitivity Syndrome (CHS). In CHS, the sensory nerves controlling the cough reflex become overly sensitive, leading to an exaggerated response to mild stimuli like talking, cold air, or strong odors.

The nerve pathways involved in CHS become sensitized, meaning the threshold required to trigger a cough is lowered. Management for this neurogenic cough differs significantly from treatment for UACS or GERD. Specialized interventions, such as behavioral cough suppression therapy delivered by a speech pathologist, help patients regain control over the reflex.

Pharmacological management involves neuromodulator medications, typically used for nerve pain. Drugs like gabapentin, pregabalin, or amitriptyline can be prescribed to reduce the hypersensitivity of the cough reflex pathway. These agents work centrally to increase the cough reflex threshold, offering relief when the traditional diagnostic approach has failed to identify a treatable cause.